Brain & Cognitive

A group of eight essential B vitamins central to energy metabolism and neurological function — deficiency is common in certain populations.

The most-studied sports supplement in history — strong evidence for strength and power, emerging evidence for cognitive benefits.

EPA and DHA from fish oil have strong cardiovascular and cognitive evidence — but dose, form, and freshness matter more than most labels suggest.

Essential for nerve function and red blood cells — genuinely corrects deficiency in vegans, older adults, and metformin users, but doesn't lower heart disease risk or boost energy if you're already replete.

A bioavailable choline source with some RCT support for cognition and power output — promising but the trial base is still thin for healthy adults.

A dual water/fat-soluble antioxidant with solid evidence for diabetic neuropathy and blood sugar support, and a reasonable safety profile.

An Ayurvedic herb with multiple RCTs supporting memory enhancement — but effects require 8-12 weeks of consistent use and are most pronounced for memory acquisition.

A choline-and-cytidine donor with a real RCT base for memory in older adults with age-related decline — thinner and less consistent for focus in generally healthy adults.

One of the most-studied herbal supplements in history, with mixed but meaningful evidence for circulation and cognition — though the large dementia-prevention trials were negative.

A sugar alcohol with good RCT evidence for reducing anxiety and panic symptoms at high doses, with additional data for PCOS — but requires gram-level dosing.

A calming amino acid from tea with solid RCT evidence for reducing stress and improving focused attention — without causing drowsiness.

An amino acid precursor to dopamine and norepinephrine with good evidence for preserving cognitive performance under acute stress — less clear benefit under normal conditions.

The carotenoids behind the biggest eye-health trial ever run — the primary endpoint missed, but the safer beta-carotene swap and subgroup data hold up.

Best-supported for fatigue in people with a chronic illness, with a smaller memory benefit in healthy adults — not the exercise-performance herb it's often sold as.

A phospholipid with moderate RCT evidence for cognitive function in older adults and cortisol modulation after exercise — effects in healthy young adults are less established.

An adaptogenic herb with solid RCT evidence for reducing mental fatigue and improving stress resilience, particularly under demanding conditions.

One of the few botanicals with head-to-head RCTs against SSRIs — comparable to fluoxetine for mild-to-moderate depression at 30 mg/day, though the trial base is still small and geographically narrow.

Broccoli-derived compound that activates the Nrf2 antioxidant pathway, with emerging evidence for metabolic and neuroprotective benefits.

A flavonoid abundant in chamomile with preliminary evidence suggesting mild relaxation and neuroprotective properties, though human data remains thin.

A medicinal mushroom with fascinating NGF-boosting potential in animal studies, but human clinical evidence remains limited to a few small pilot trials.

A 2025 podcast-fueled nootropic trend built on real but narrow human data — single-dose trials show a memory signal, but daily use carries a serious, under-discussed serotonin syndrome risk.

Pyrroloquinoline quinone shows mitochondrial support in cell and animal studies, but human evidence is limited to small pilot trials with modest results.